Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis.
Surendra DasariAngela DispenzieriShareef MansourPrasuna MuppaPaul J KurtinJason D TheisJulie A VranaMartha GroganTaxiarchis KourelisMorie A GertzEllen Darcy McPhailPublished in: ESC heart failure (2020)
In patients suspected of having cardiac amyloidosis based on cardiac scintigraphy, LC-MS/MS typing of Congophilic deposits in pre-existing biopsy specimens from non-cardiac sites may help establish the cardiac amyloid type, obviating the need for EMB. However, if the amyloid type identified in the non-cardiac site is not in keeping with other clinical features, then EMB for typing the cardiac amyloid might be indicated.